Life Sciences Times

TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer

Nordic Capital and Astorg Invest in Pharmaceutical Technology and Advanced Analytics Company Cytel

Aceto Establishes Chemical Manufacturing and R&D Capabilities in the U.S. Through Acquisition of IsleChem

Servier to Acquire Cambridge-Based Agios Pharmaceuticals’ Oncology Business

Motility Medical Starts Human Trials for New Medical Device to Treat Constipation

New UK Covid-19 strain detected in Australia, Italy

New lethal Covid variant puts world on high alert

Study finds high risk factors of mortality from Covid-19

Hospitalized male Covid patients at 30% higher risk of dying

Indian pharma companies to benefit from improving US demand: Report